Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a variety of hematological malignancies. An HLA-matched related donor is available for only 20 to 30% of ...
The mechanism by which high levels of FM led to better survival particularly in leukemia patients remains unknown. One could speculate that donor T cells, which are continuously exposed to healthy ...
Editor’s Note: This article previously appeared in a different format as part of The Atlantic’s Notes section, retired in 2021. A reader revives our collection of miscarriage stories with an uncommon ...